30.09MMarket Cap-2269P/E (TTM)
0.877High0.812Low550.74KVolume0.819Open0.845Pre Close463.92KTurnover1.86%Turnover RatioLossP/E (Static)35.84MShares5.97052wk High-5.06P/B24.84MFloat Cap0.46452wk Low--Dividend TTM29.59MShs Float12.470Historical High--Div YieldTTM7.68%Amplitude0.464Historical Low0.842Avg Price1Lot Size
BriaCell Therapeutics Stock Forum
5 MINUTES AGO, 7:50 AM EDT
VIA GLOBENEWSWIRE
35 sites active and enrolling in pivotal Phase 3 study of Bria-IMT™ combination with immune check point inhibitor in metastatic breast cancer (MBC)
Primary endpoint is overall survival (OS) with Bria-IMT™ regimen plus Check Point Inhibitor (CPI) vs treatment of physician's choice
Interim data analysis planned at 144 eve...
Bria-IMT Combo Elicits Overall Survival Benefit in Metastatic Breast Cancer
No comment yet